RAYMOND JAMES & ASSOCIATES - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$448,000
-66.5%
22,207
-38.0%
0.00%
-100.0%
Q2 2021$1,337,000
+78.7%
35,835
+22.4%
0.00%0.0%
Q1 2021$748,000
+53.6%
29,272
+32.3%
0.00%0.0%
Q4 2020$487,000
+20.2%
22,124
-1.6%
0.00%0.0%
Q3 2020$405,000
-29.1%
22,495
+0.1%
0.00%0.0%
Q2 2020$571,000
+37.3%
22,478
-0.7%
0.00%0.0%
Q1 2020$416,000
-23.2%
22,633
-8.0%
0.00%0.0%
Q4 2019$542,000
+54.4%
24,611
+0.7%
0.00%
Q3 2019$351,00024,4460.00%
Other shareholders

There were no reported owners of DICERNA PHARMACEUTICALS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of DICERNA PHARMACEUTICALS INC shareholders